Alentis Therapeutics AG
Developing Claudin-1 antibodies for cancer and fibrosis
Read moreThese trailblazers have scaled beyond expectations—becoming industry leaders, job creators, and global ambassadors of Swiss excellence. Their journeys reflect the power of vision, resilience, and innovation. Discover the startups that are transforming industries and inspiring the world shapers of tomorrow.
Developing Claudin-1 antibodies for cancer and fibrosis
Read moreOnline tools to edit PDFs
Read moreThe platform for building powerful brand experience
Read moreCancer vaccines
Read moreConquer liver diseases and saves lives
Read moreSmart Data Capture
Read moreDeveloping the next generation bacterial cancer therapy
Read moreBusiness software for SMEs
Read more